Events
Biotech in Europe: act for global impact
A unique gathering of biotech and biopharma leaders, policymakers, academics, diplomats and key stakeholders, to explore what this new EU initiative could mean for our sector and how Belgium can take a leading role.
Biotech is entering a new chapter. As announced by Commission President Ursula von der Leyen, the EU Biotech Act is set to become a cornerstone of Europe’s strategy to boost innovation, biomanufacturing and sustainable growth. But how can we turn that ambition into concrete opportunities for innovation, investment, and impact? What does this mean for Belgium’s thriving biotech and biopharma ecosystem? And how can our sector seize the opportunities this bold initiative offers?
Programme
13.30: Registration & welcome coffee
14.30 : Plenary Session
Welcome Address
- Geoffrey Pot – Chair of bio.be/essenscia
Contribution from Olivér Várhelyi, European Commissioner for Health and Animal Welfare
Panel Debate – Regulate to Innovate
How can regulatory frameworks enable innovation?
- Marc Martens – Partner and Co-head, Bird & Bird International Life Sciences & Healthcare Group
- Claire Skentelbery – CEO, EuropaBio
- Veronique Toully – Head of Sustainability, Risks & Corporate Affairs, UCB
Panel Debate – Funding for the Future
What funding mechanisms can fuel biotech innovation in Europe?
- Floor Stam – CEO, Remynd
- Benoît van den Hove – CEO, Euronext Brussels
- Koenraad Van Loo – CEO, SFPI-FPIM
Closing Remarks from Maxime Prévot – Deputy Prime Minister and Minister of Foreign Affairs, European Affairs and Development Cooperation
16.15: Networking reception
17.30: End